Monday, May 27, 2013 WSJ.com: Europe Home: Bausch Buy Will Speed Drug Firm's Reshuffling WSJ.com: Europe Home Europe Home Bausch Buy Will Speed Drug Firm's Reshuffling May 28th 2013, 01:01 Valeant agreed to buy global eye-care giant Bausch & Lomb for $4.5 billion, a move that highlights a resurgence in private-equity deal making after years spent in the doldrums. Media files: MK-CD530_VALEAN_A_20130527190955.jpg (image/jpeg) You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions Tweet
